Global Cabozantinib Market Forecast: Innovation and Oncology Advances Set to Drive Strong Growth Through 2032 https://dataintelo.com/report/global-cabozantinib-market The Cabozantinib Market is positioned for significant expansion, driven by rising cancer prevalence, increased awareness of targeted therapies, and ongoing advancements in oncology research. Cabozantinib, a potent tyrosine kinase inhibitor, has emerged as a crucial treatment option in various cancer types, particularly renal cell carcinoma and hepatocellular carcinoma. With cancer continuing to be one of the leading causes of death worldwide, governments and healthcare organizations are accelerating drug development initiatives. Cabozantinib’s growing application in advanced cancer treatment protocols and its efficacy in managing resistant tumor types is fueling both clinical interest and commercial potential.